Media center

Phnom Penh, Cambodia, July 11, 2012 – DKSH Healthcare and GlaxoSmithKline (GSK) have signed an agreement under which DKSH provides logistics, warehousing, distribution, collection, and credit management services to GSK in Cambodia.

Under the agreement, DKSH Healthcare distributes the complete portfolio of GSK pharmaceutical and vaccine products currently available in Cambodia. GSK’s decision to trust DKSH with the distribution of their portfolio was due to DKSH’s broad local knowledge, well-established infrastructure, channel management expertise, successful track record, and transparency.

Romeo David, GSK Country Manager for Cambodia, Laos, and Pacific Islands, said: “This agreement with DKSH Healthcare supports our business expansion and facilitates increasing access to quality GSK pharmaceutical, vaccines, and non-prescription products through its strong and wide distribution network in Cambodia. In the past several years, DKSH has built a strong and proactive organization in Cambodia.”

“For us, it is a fantastic opportunity to explore new business solutions and work with leading pharmaceutical brands. It also allows us to establish DKSH as the quality reference for leading healthcare products in Cambodia. We can proudly confirm our leadership in this market segment and as the true No. 1 Market Expansion Services provider in Cambodia,” commented Nicolas Chabanier, General Manager, Business Unit Healthcare, Cambodia. “With growing healthcare awareness and needs, the demand for quality healthcare products is increasing, and we are looking forward to a successful long-term partnership with GSK.”

is the leading Market Expansion Services Group with a focus on Asia. As the term "Market Expansion Services" suggests, DKSH helps other companies and brands to grow their business in new or existing markets.

Publicly listed on the SIX Swiss Exchange since March 2012, DKSH is a global company headquartered in Zurich. With 650 business locations in 35 countries – 630 of them in Asia – and over 24,000 specialized staff, DKSH generated Net Sales of CHF 7.3 billion in 2011.

is the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia, offering a wide range of solutions that extend from product feasibility studies and registration to importation, customs clearance, marketing and sales, to physical distribution, invoicing and cash collection. Products available through DKSH Healthcare include ethical pharmaceuticals, consumer health, over-the-counter (OTC), as well as medical devices.

With 150 business locations in 13 countries and over 8,000 specialized staff, Business Unit Healthcare serves over 160,000 customers and generated Net Sales of around CHF 2.9 billion in 2011.

- one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit

.